Skip to main content
Top
Published in: Diabetologia 11/2006

01-11-2006 | Article

Beta cell death in hyperglycaemic Psammomys obesus is not cytokine-mediated

Authors: A. Jörns, K. J. Rath, O. Bock, S. Lenzen

Published in: Diabetologia | Issue 11/2006

Login to get access

Abstract

Aims/hypothesis

It has recently been proposed that IL-1β may be responsible for beta cell death in type 2 diabetes mellitus. Major support for this assumption was derived from experiments in the gerbil Psammomys obesus (sand rat), a model for nutritionally induced non-insulin-dependent type 2 diabetes. Using gerbil-specific primers for the analysis of gene expression, we investigated the validity of this hypothesis.

Methods

Gene expression was analysed by real-time RT-PCR of isolated and laser-microdissected islets and by in situ RT-PCR, both in beta cells and in immune cells, as well as in lymph nodes and spleen.

Results

We were unable to detect Il-1β and the IL-1β-inducible enzyme inducible nitric oxide synthase (iNos) by in situ RT-PCR, either in the pancreatic beta cells, or in the small number of non-activated immune cells of healthy and diabetic Psammomys obesus after 1 and 3 weeks on a high-energy diet. Very low levels of Il-1β and iNos mRNA were detectable in collagenase-isolated and laser-microdissected islets of normoglycaemic gerbils by real-time RT-PCR without any increase of these mRNAs in islets from diabetic animals. These results were confirmed by electron microscopy with immunogold staining for IL-1β and insulin.

Conclusions/interpretation

The diabetic syndrome induced in Psammomys obesus by high-energy diet is a classical type 2 diabetes model, which does not show any evidence of an involvement of the proinflammatory cytokine IL-1β or of activated immune cells in its pathogenesis. This is clearly at variance with the situation in type 1 diabetes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Eizirik DL, Mandrup-Poulsen T (2001) A choice of death — the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 44:2115–2133PubMedCrossRef Eizirik DL, Mandrup-Poulsen T (2001) A choice of death — the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 44:2115–2133PubMedCrossRef
2.
go back to reference Lally FJ, Bone AJ (2002) Animal models of type 1 diabetes. In: Pickup JC, Williams G (eds) Textbook of Diabetes. Blackwell Scientific, Oxford, pp 19.11–19.17 Lally FJ, Bone AJ (2002) Animal models of type 1 diabetes. In: Pickup JC, Williams G (eds) Textbook of Diabetes. Blackwell Scientific, Oxford, pp 19.11–19.17
3.
go back to reference Eisenbarth GS (2005) Type I diabetes. Molecular, cellular and clinical immunology. Oxford University Press, Oxford Eisenbarth GS (2005) Type I diabetes. Molecular, cellular and clinical immunology. Oxford University Press, Oxford
4.
go back to reference Donath MY, Storling J, Maedler K, Mandrup-Poulsen T (2003) Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. J Mol Med 81:455–470PubMedCrossRef Donath MY, Storling J, Maedler K, Mandrup-Poulsen T (2003) Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. J Mol Med 81:455–470PubMedCrossRef
5.
go back to reference Donath MY, Halban PA (2004) Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia 47:581–589PubMedCrossRef Donath MY, Halban PA (2004) Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia 47:581–589PubMedCrossRef
6.
go back to reference Donath MY, Ehses JA, Maedler K et al (2005) Mechanisms of beta-cell death in type 2 diabetes. Diabetes 54(Suppl 2):S108–S113PubMed Donath MY, Ehses JA, Maedler K et al (2005) Mechanisms of beta-cell death in type 2 diabetes. Diabetes 54(Suppl 2):S108–S113PubMed
7.
8.
go back to reference Donath MY, Gross DJ, Cerasi E, Kaiser N (1999) Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 48:738–744PubMed Donath MY, Gross DJ, Cerasi E, Kaiser N (1999) Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 48:738–744PubMed
9.
go back to reference Maedler K, Sergeev P, Ris F et al (2002) Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851–860PubMedCrossRef Maedler K, Sergeev P, Ris F et al (2002) Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851–860PubMedCrossRef
10.
go back to reference Shafrir E, Gutman A (1993) Psammomys obesus of the Jerusalem colony: a model for nutritionally induced, non-insulin-dependent diabetes. J Basic Clin Physiol Pharmacol 4:83–99PubMed Shafrir E, Gutman A (1993) Psammomys obesus of the Jerusalem colony: a model for nutritionally induced, non-insulin-dependent diabetes. J Basic Clin Physiol Pharmacol 4:83–99PubMed
11.
go back to reference Shafrir E, Ziv E, Kalman R (2006) Nutritionally induced diabetes in desert rodents as models of type 2 diabetes: Acomys cahirinus (spiny mice) and Psammomys obesus (desert gerbil). ILAR J 47:212–224PubMed Shafrir E, Ziv E, Kalman R (2006) Nutritionally induced diabetes in desert rodents as models of type 2 diabetes: Acomys cahirinus (spiny mice) and Psammomys obesus (desert gerbil). ILAR J 47:212–224PubMed
12.
go back to reference Cnop M, Welsh N, Jonas JC, Jörns A, Lenzen S, Eizirik DL (2005) Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54(Suppl 2):S97–S107PubMed Cnop M, Welsh N, Jonas JC, Jörns A, Lenzen S, Eizirik DL (2005) Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54(Suppl 2):S97–S107PubMed
13.
go back to reference Welsh N, Cnop M, Kharroubi I et al (2005) Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or the type 2 diabetes milieu to human pancreatic islets? Diabetes 54:3238–3244PubMed Welsh N, Cnop M, Kharroubi I et al (2005) Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or the type 2 diabetes milieu to human pancreatic islets? Diabetes 54:3238–3244PubMed
14.
go back to reference Jörns A, Tiedge M, Ziv E, Shafrir E, Lenzen S (2002) Gradual loss of pancreatic beta-cell insulin, glucokinase and GLUT2 glucose transporter immunoreactivities during the time course of nutritionally induced type-2 diabetes in Psammomys obesus (sand rat). Virchows Arch 440:63–69PubMedCrossRef Jörns A, Tiedge M, Ziv E, Shafrir E, Lenzen S (2002) Gradual loss of pancreatic beta-cell insulin, glucokinase and GLUT2 glucose transporter immunoreactivities during the time course of nutritionally induced type-2 diabetes in Psammomys obesus (sand rat). Virchows Arch 440:63–69PubMedCrossRef
15.
go back to reference Lenzen S, Tiedge M, Elsner M et al (2001) The LEW.1AR1/Ztm-iddm rat: a new model of spontaneous insulin-dependent diabetes mellitus. Diabetologia 44:1189–1196PubMedCrossRef Lenzen S, Tiedge M, Elsner M et al (2001) The LEW.1AR1/Ztm-iddm rat: a new model of spontaneous insulin-dependent diabetes mellitus. Diabetologia 44:1189–1196PubMedCrossRef
16.
go back to reference Jörns A, Günther A, Hedrich HJ, Wedekind D, Tiedge M, Lenzen S (2005) Immune cell infiltration, cytokine expression, and beta-cell apoptosis during the development of type 1 diabetes in the spontaneously diabetic LEW.1AR1/Ztm-iddm rat. Diabetes 54:2041–2052PubMed Jörns A, Günther A, Hedrich HJ, Wedekind D, Tiedge M, Lenzen S (2005) Immune cell infiltration, cytokine expression, and beta-cell apoptosis during the development of type 1 diabetes in the spontaneously diabetic LEW.1AR1/Ztm-iddm rat. Diabetes 54:2041–2052PubMed
17.
go back to reference Schutze K, Lahr G (1998) Identification of expressed genes by laser-mediated manipulation of single cells. Nat Biotechnol 16:737–742PubMedCrossRef Schutze K, Lahr G (1998) Identification of expressed genes by laser-mediated manipulation of single cells. Nat Biotechnol 16:737–742PubMedCrossRef
18.
go back to reference Bock O, Schlue J, Mengel M, Busche G, Serinsoz E, Kreipe H (2004) Thrombopoietin receptor (Mpl) expression by megakaryocytes in myeloproliferative disorders. J Pathol 203:609–615PubMedCrossRef Bock O, Schlue J, Mengel M, Busche G, Serinsoz E, Kreipe H (2004) Thrombopoietin receptor (Mpl) expression by megakaryocytes in myeloproliferative disorders. J Pathol 203:609–615PubMedCrossRef
19.
go back to reference Souza KL, Elsner M, Mathias PC, Lenzen S, Tiedge M (2004) Cytokines activate genes of the endocytotic pathway in insulin-producing RINm5F cells. Diabetologia 47:1292–1302PubMedCrossRef Souza KL, Elsner M, Mathias PC, Lenzen S, Tiedge M (2004) Cytokines activate genes of the endocytotic pathway in insulin-producing RINm5F cells. Diabetologia 47:1292–1302PubMedCrossRef
20.
go back to reference Arnush M, Scarim AL, Heitmeier MR, Kelly CB, Corbett JA (1998) Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes. J Immunol 160:2684–2691PubMed Arnush M, Scarim AL, Heitmeier MR, Kelly CB, Corbett JA (1998) Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes. J Immunol 160:2684–2691PubMed
21.
go back to reference Hirai H, Kaino Y, Ito T, Kida K (2000) Analysis of cytokine mRNA expression in pancreatic islets of nonobese diabetic mice. J Pediatr Endocrinol Metab 13:91–98PubMed Hirai H, Kaino Y, Ito T, Kida K (2000) Analysis of cytokine mRNA expression in pancreatic islets of nonobese diabetic mice. J Pediatr Endocrinol Metab 13:91–98PubMed
22.
go back to reference Rabinovitch A, Suarez-Pinzon WL (1998) Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 55:1139–1149PubMedCrossRef Rabinovitch A, Suarez-Pinzon WL (1998) Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 55:1139–1149PubMedCrossRef
23.
go back to reference Jörns A, Kubat B, Tiedge M et al (2004) Pathology of the pancreas and other organs in the diabetic LEW.1AR1/Ztm-iddm rat, a new model of spontaneous insulin-dependent diabetes mellitus. Virchows Arch 444:183–189PubMedCrossRef Jörns A, Kubat B, Tiedge M et al (2004) Pathology of the pancreas and other organs in the diabetic LEW.1AR1/Ztm-iddm rat, a new model of spontaneous insulin-dependent diabetes mellitus. Virchows Arch 444:183–189PubMedCrossRef
24.
go back to reference Elouil H, Cardozo AK, Eizirik DL, Henquin JC, Jonas JC (2005) High glucose and hydrogen peroxide increase c-Myc and haeme-oxygenase 1 mRNA levels in rat pancreatic islets without activating NFkappaB. Diabetologia 48:496–505PubMedCrossRef Elouil H, Cardozo AK, Eizirik DL, Henquin JC, Jonas JC (2005) High glucose and hydrogen peroxide increase c-Myc and haeme-oxygenase 1 mRNA levels in rat pancreatic islets without activating NFkappaB. Diabetologia 48:496–505PubMedCrossRef
25.
go back to reference Kaiser N, Yuli M, Uckaya G et al (2005) Dynamic changes in beta-cell mass and pancreatic insulin during the evolution of nutrition-dependent diabetes in Psammomys obesus: impact of glycemic control. Diabetes 54:138–145PubMed Kaiser N, Yuli M, Uckaya G et al (2005) Dynamic changes in beta-cell mass and pancreatic insulin during the evolution of nutrition-dependent diabetes in Psammomys obesus: impact of glycemic control. Diabetes 54:138–145PubMed
26.
go back to reference Kaiser N, Nesher R, Donath MY et al (2005) Psammomys obesus, a model for environment–gene interactions in type 2 diabetes. Diabetes 54(Suppl 2):S137–S144PubMed Kaiser N, Nesher R, Donath MY et al (2005) Psammomys obesus, a model for environment–gene interactions in type 2 diabetes. Diabetes 54(Suppl 2):S137–S144PubMed
27.
go back to reference Rathcke CN, Johansen JS, Vestergaard H (2006) YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance. Inflamm Res 55:53–59PubMedCrossRef Rathcke CN, Johansen JS, Vestergaard H (2006) YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance. Inflamm Res 55:53–59PubMedCrossRef
28.
Metadata
Title
Beta cell death in hyperglycaemic Psammomys obesus is not cytokine-mediated
Authors
A. Jörns
K. J. Rath
O. Bock
S. Lenzen
Publication date
01-11-2006
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 11/2006
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0413-2

Other articles of this Issue 11/2006

Diabetologia 11/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.